Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Juillerat

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|June 28, 2015
High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort StudyLuc Biedermann, Nicolas Fournier, Benjamin Misselwitz, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis|June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should knowPhilipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Gastrointestinal Endoscopy|May 18, 2021
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Sarah Henchoz, Luc Biedermann, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activitiesPhilipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Journal of Crohn'S & Colitis|June 9, 2014
The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patientsMarijana Protic, Frank Seibold, Alain Schoepfer, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|June 28, 2015
High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort StudyLuc Biedermann, Nicolas Fournier, Benjamin Misselwitz, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|June 10, 2025
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 studyMiguel Regueiro, Monika Fischer, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis|June 28, 2020
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should knowPhilipp Schreiner, Nicolas J Mueller, Jan Fehr, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Gastrointestinal Endoscopy|May 18, 2021
Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitisAlain M Schoepfer, Sarah Henchoz, Luc Biedermann, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Fatigue in inflammatory bowel disease and its impact on daily activitiesPhilipp Schreiner, Jean-Benoît Rossel, Luc Biedermann, et al.
Therapeutic Advances in Gastroenterology|August 11, 2023
Because I'm happy - positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort studyBrian M Lang, Martina Ledergerber, Sebastian Bruno Ulrich Jordi, et al.
Pageof 11